Oxford Immunotec Global PLC Total Revenue

Oxford Immunotec Global PLC (OXFD) currently reports a total revenue of $57M as of September 2020. That compares with $71M in the prior-year period — down 19.3% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Oxford Immunotec Global PLC's total revenue history and peer comparisons.

Oxford Immunotec Global PLC's total revenue decreased from $71M to $57M — a 19.3% year-over-year decrease (period ending September 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Oxford Immunotec Global PLC's total revenue of $57M is lower than the Healthcare sector average of $110B. That is roughly 99.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Oxford Immunotec Global PLC reported $57M in total revenue as of September 2020. That compares with $71M in the prior-year period — down 19.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $57M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Oxford Immunotec Global PLC, and consider following OXFD for alerts when major investors trade the stock.